RecruitingPhase 4NCT05845424

High-intensity Statin and Ezetimibe Therapy for Asymptomatic Patients With Positive Coronary Calcium

Comparison of Efficacy and Safety of High-Intensity Statin and Ezetimibe Combination Versus StanDard carE in AsymptomatiC PatIentS wIth Presence of COroNary Artery CALCIUM (DECISION-CAL)

Sponsor

Samsung Medical Center

Enrollment

6,000 participants

Start Date

Jul 3, 2023

Study Type

INTERVENTIONAL

Conditions

Metabolic Syndrome Dyslipidemias Coronary Artery Calcification

Summary

The aim of this study is to compare safety and efficacy between the aggressive treatment with combination of high-intensity statin and ezetimibe and the current standard lipid lowering treatment in asymptomatic patients with presence of coronary calcification.

Eligibility

Min Age: 40 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called Guideline directed statin therapy and a drug called High intensity statin plus ezetimibe therapy for people with coronary artery calcification, dyslipidemias, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include aged 40 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.